Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Buy" from Analysts

Retrieved on: 2021-06-21 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,678,763 shares of the biotechnology company's stock worth $19,866,000 after purchasing an additional 159,918 shares in ...

Article found on: www.marketbeat.com